{
    "balance": {
        "data": [
            "CONSOLIDATED BALANCE SHEETS\tDecember 31,\tDecember 31,\t(In millions except share and per share amounts)\t2023\t2022\tAssets\tCurrent assets:\tCash and cash equivalents\t$\t8,077\t$\t8,524\tAccounts receivable, less allowances of $\t193\tand $\t189\t8,221\t8,115\tInventories\t5,088\t5,634\tContract assets, net\t1,443\t1,312\tOther current assets\t1,760\t1,644\tTotal current assets\t24,589\t25,229\tProperty, plant and equipment, net\t9,448\t9,280\tAcquisition-related intangible assets, net\t16,670\t17,442\tOther assets\t3,999\t4,007\tGoodwill\t44,020\t41,196\tTotal assets\t$\t98,726\t$\t97,154\tLiabilities, redeemable noncontrolling interest and equity\tCurrent liabilities:\tShort-term obligations and current maturities of long-term obligations\t$\t3,609\t$\t5,579\tAccounts payable\t2,872\t3,381\tAccrued payroll and employee benefits\t1,596\t2,095\tContract liabilities\t2,689\t2,601\tOther accrued expenses\t3,246\t3,354\tTotal current liabilities\t14,012\t17,010\tDeferred income taxes\t1,922\t2,849\tOther long-term liabilities\t4,642\t4,238\tLong-term obligations\t31,308\t28,909\tCommitments and contingencies (Note 12)\tRedeemable noncontrolling interest\t118\t116\tEquity:\tThermo Fisher Scientific Inc. shareholders  equity:\tPreferred stock, $\t100\tpar value,\t50,000\tshares authorized;\tnone\tissued\tCommon stock, $\t1\tpar value,\t1,200,000,000\tshares authorized;\t442,188,634\tand\t440,668,112\tshares issued\t442\t441\tCapital in excess of par value\t17,286\t16,743\tRetained earnings\t47,364\t41,910\tTreasury stock at cost,\t55,541,290\tand\t50,157,275\tshares\t(\t15,133\t)\t(\t12,017\t)\tAccumulated other comprehensive income/(loss)\t(\t3,224\t)\t(\t3,099\t)\tTotal Thermo Fisher Scientific Inc. shareholders  equity\t46,735\t43,978\tNoncontrolling interests\t(\t11\t)\t54\tTotal equity\t46,724\t44,032\tTotal liabilities, redeemable noncontrolling interest and equity\t$\t98,726\t$\t97,154\tThe accompanying notes are an integral part of these consolidated financial statements.\t33\tTHERMO FISHER SCIENTIFIC INC.\tCONSOLIDATED STATEMENTS OF INCOME\tYear Ended\tDecember 31,\tDecember 31,\tDecember 31,\t(In millions except per share amounts)\t2023\t2022\t2021\tRevenues\tProduct revenues\t$\t25,243\t$\t28,548\t$\t30,361\tService revenues\t17,614\t16,367\t8,850\tTotal revenues\t42,857\t44,915\t39,211\tCosts and operating expenses:\tCost of product revenues\t13,168\t14,247\t13,594\tCost of service revenues\t12,589\t11,697\t5,979\tSelling, general and administrative expenses\t8,445\t8,993\t8,007\tResearch and development expenses\t1,337\t1,471\t1,406\tRestructuring and other costs\t459\t114\t197\tTotal costs and operating expenses\t35,998\t36,522\t29,183\tOperating income\t6,859\t8,393\t10,028\tInterest income\t879\t272\t43\tInterest expense\t(\t1,375\t)\t(\t726\t)\t(\t536\t)\tOther income/(expense)\t(\t65\t)\t(\t104\t)\t(\t694\t)\tIncome before income taxes\t6,298\t7,835\t8,841\tProvision for income taxes\t(\t284\t)\t(\t703\t)\t(\t1,109\t)\tEquity in earnings/(losses) of unconsolidated entities\t(\t59\t)\t(\t172\t)\t(\t4\t)\tNet income\t5,955\t6,960\t7,728\tLess: net (losses) income attributable to noncontrolling interests and redeemable noncontrolling interest\t(\t40\t)\t10\t3\tNet income attributable t"
        ],
        "timestamp": "2025-01-21_09-41-24"
    }
}